This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Publishing athlete doping details can comply with data rules, top EU court says (update*)

By Júlia Tar ( July 14, 2026, 10:02 GMT | Insight) -- Publishing the names of professional athletes sanctioned for doping can be compatible with the EU's data privacy law if authorities carry out an assessment before disclosure and ensure publication is proportionate, the EU's top court has ruled. The judgment comes after four athletes said Austria's rules requiring the country's anti-doping authorities to publish the names of sanctioned athletes, their sport, and related sanction, unlawfully processed health data and breached the EU's General Data Protection Regulation. Publishing the names of professional athletes sanctioned for doping can be compatible with the EU's data privacy law if authorities carry out an assessment before disclosure and ensure publication is proportionate, the EU's top court has ruled in a case involving an Austrian anti-doping organization....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login